Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intravesical Chemotherapy in UTUC
NCT02547350Phase 2Unknown
- Start
- Sep 2015
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of epirubicin, pirarubicin in upper tract urothelial carcinoma (UTUC). Status: unknown.
02
Drugs
epirubicinpirarubicin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT02547350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547350.